Surrozen, Inc./DE·4

Oct 12, 9:59 PM ET

Yeh Wen-Chen 4

4 · Surrozen, Inc./DE · Filed Oct 12, 2022

Insider Transaction Report

Form 4
Period: 2022-07-01
Yeh Wen-Chen
Chief Scientific Officer
Transactions
  • Award

    Option (right to buy)

    2022-10-10+29,56729,567 total
    Exercise: $2.16From: 2021-02-01Exp: 2031-02-22Common Stock (29,567 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2022-10-105,5620 total
    Exercise: $10.77From: 2021-02-01Exp: 2031-02-22Common Stock (5,562 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2022-10-1029,5670 total
    Exercise: $10.77From: 2021-02-01Exp: 2031-02-22Common Stock (29,567 underlying)
  • Award

    Option (right to buy)

    2022-07-01+500500 total
    Exercise: $3.15From: 2022-07-21Exp: 2032-07-01Common Stock (500 underlying)
  • Award

    Option (right to buy)

    2022-10-10+5,5625,562 total
    Exercise: $2.16From: 2021-02-01Exp: 2031-02-22Common Stock (5,562 underlying)
Footnotes (3)
  • [F1]The reporting person agreed to cancellation of an option granted to him on February 23, 2021, in exchange for a new option having a lower exercise price.
  • [F2]The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date.
  • [F3]The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 7/21/2022, subject to the reporting person's continued employment through the applicable vesting date.

Documents

1 file
  • 4
    primary_01.xmlPrimary

    PRIMARY DOCUMENT